Access to the investigational treatment after the study ends depends on regulatory approvals. The study team will inform you of the next steps based on the trial’s outcomes.
Uncomplicated UTI – Past Innovative Treatments for Urinary Tract Infections
About the Urinary Tract Infection Research Study
This phase 2, double-blind, randomized Urinary Tract Infection Research Study aimed to evaluate the effectiveness of a new treatment in combination with antibiotics. The study focused on reducing the impact of drug-resistant E. coli infections in patients with active acute uncomplicated UTIs through innovative therapies.
In Part 1, the study assessed optimal dosing for the investigational drug among 30 participants, focusing on pharmacokinetics and safety. Part 2 involved randomly assigning participants to receive either the study drug + antibiotics or placebo + antibiotics, to evaluate the treatment’s efficacy and safety.
Current Status
Not Recruiting
Study Count
01
Study Information
Urinary Tract Infection - UTI
| Study Name | Protocol Number | Sponsor |
|---|---|---|
| Urinary Tract Infection | LBx-2001 | Locus Bioscience |
Frequently Asked Questions
Can pregnant or breastfeeding women participate in this study?
No, pregnant or breastfeeding women are typically excluded from this study to ensure the safety of both the mother and child.
Will I be able to learn about the overall results of the study?
Yes, participants will be informed about the general findings once the study is completed, though individual results may not be shared. The research team can provide updates as they become available.
Unlock New Opportunities in Clinical Research - Join Today!
We're here and eager to assist. Reach out to Hightower Clinical Research in Oklahoma City, OK for further details on how we can support you.
Get Involved Today!
© Copyright 2024 – Hightower Clinical. CREATED BY DIGITAL AUXILIUS.